Xing Lin Selected Research

Xing Lin Research Topics

Disease

24	Fibrosis (Cirrhosis) 03/2022 - 01/2012
16	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2012
10	Neoplasms (Cancer) 01/2022 - 08/2015
6	Inflammation (Inflammations) 03/2022 - 01/2014
6	Necrosis 03/2022 - 01/2012
6	Body Weight (Weight, Body) 01/2019 - 05/2013
5	Cognitive Dysfunction 01/2021 - 01/2014
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 01/2014
3	Neuroinflammatory Diseases 07/2022 - 04/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
3	Non-alcoholic Fatty Liver Disease 11/2020 - 03/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2020
3	Reperfusion Injury 01/2017 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2014
3	Infections 11/2013 - 08/2009
2	Lung Neoplasms (Lung Cancer) 05/2022 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
2	Amblyopia (Lazy Eye) 04/2021 - 09/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2017
2	Adenocarcinoma 12/2020 - 12/2019
2	Lipidoses 11/2020 - 12/2018
2	Alcoholic Fatty Liver 01/2020 - 12/2018
2	Pain (Aches) 01/2020 - 11/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 05/2013
2	Diabetes Mellitus 08/2018 - 01/2015
2	Infarction (Infarctions) 01/2014 - 01/2014
2	Myocardial Infarction 01/2014 - 01/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2013 - 01/2012
1	Ischemia 07/2022
1	Stroke (Strokes) 07/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022
1	Hypersensitivity (Allergy) 04/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
8	CollagenIBA 01/2022 - 01/2012
5	Biological ProductsIBA 01/2022 - 10/2013
5	didyminIBA 01/2022 - 01/2016
5	Phosphatidylethanolamine Binding ProteinIBA 01/2019 - 01/2016
4	CytokinesIBA 07/2022 - 01/2012
4	Transaminases (Aminotransferases)IBA 01/2022 - 04/2014
4	tormentic acidIBA 01/2022 - 04/2014
4	Pharmaceutical PreparationsIBA 01/2020 - 06/2012
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
4	Hydroxyproline (4 Hydroxyproline)IBA 06/2014 - 01/2012
4	GenisteinIBA 01/2014 - 01/2012
3	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 03/2018
3	Glycerophospholipids (Phosphoglycerides)IBA 03/2022 - 01/2022
3	helenalinIBA 03/2022 - 06/2014
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 10/2012
3	Galactose (Galactopyranose)FDA LinkGeneric 01/2021 - 01/2014
3	GalactosamineIBA 01/2021 - 01/2014
3	LipopolysaccharidesIBA 01/2021 - 01/2014
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2014
3	methyl helicterateIBA 01/2019 - 10/2012
3	Interleukin-6 (Interleukin 6)IBA 08/2018 - 01/2012
3	17- methoxyl- 7- hydroxy- benzene- furanchalconeIBA 01/2017 - 01/2014
3	homoorientin (isoorientin)IBA 07/2016 - 11/2013
3	Caspase 3 (Caspase-3)IBA 08/2015 - 01/2014
3	Laminin (Merosin)IBA 06/2014 - 10/2012
3	Hyaluronic Acid (Hyaluronan)IBA 06/2014 - 10/2012
2	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2022
2	CaspasesIBA 01/2022 - 07/2016
2	levodopa methyl esterIBA 04/2021 - 09/2013
2	methyl helicterilateIBA 03/2021 - 10/2019
2	madecassosideIBA 01/2021 - 09/2014
2	Interleukin-33IBA 12/2020 - 12/2019
2	asiatic acidIBA 01/2020 - 12/2018
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 09/2012
2	CreatinineIBA 01/2019 - 05/2013
2	locostatinIBA 10/2018 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 08/2018 - 03/2018
2	CholesterolIBA 08/2018 - 03/2018
2	EnzymesIBA 03/2018 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 07/2016
2	Peanut OilIBA 01/2017 - 10/2012
2	Polysaccharides (Glycans)IBA 12/2016 - 01/2014
2	raf KinasesIBA 08/2016 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2015
2	AntioxidantsIBA 09/2015 - 10/2012
2	4'-methoxy-3',5,7-trihydroxyisoflavoneIBA 04/2015 - 03/2015
2	Amyloid beta-PeptidesIBA 04/2015 - 03/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2015 - 01/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014 - 01/2012
2	Messenger RNA (mRNA)IBA 01/2014 - 02/2013
2	Saline SolutionIBA 01/2014 - 11/2013
2	Taurine FDA Link 10/2013 - 01/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2013 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013 - 01/2012
1	AntagomirsIBA 07/2022
1	Untranslated RNA (Noncoding RNA)IBA 07/2022
1	Long Noncoding RNAIBA 07/2022
1	Oxygen (Dioxygen)IBA 07/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2022
1	Immunoglobulin E (IgE)IBA 04/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2022
1	anlotinibIBA 01/2022

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2012
2	Radiotherapy 01/2022 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2016 - 05/2013
2	Traditional Medicine (Folk Remedies) 01/2015 - 11/2013